Skip to main content
OpenTrials
Completed

NCT Number: NCT01280539

The Effect of Transcutaneous Electrical Nerve Stimulation (TENS) in Multiple Sclerosis

In this study the researchers want to investigate the effects of long-term transcutaneous electrical nerve stimulation on the cortical excitability of persons with multiple sclerosis.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–68 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hasselt University (BIOMED)

Diepenbeek, Limburg, 3590, Belgium

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Expanded Disability Status Scale (EDSS) scores between 2 and 6.5
  • Stable MS (no relapse during the last 3 months before study onset)
  • sensory impairment
  • age: between 18 and 68 years old

Exclusion criteria

  • Patients with other pathologies associated with peripheral and/or central sensory dysfunction or under psychotropic or antiepileptic medication

Treatment and study plan

Transcutaneous electrical nerve stimulation

Device

3 weeks, 5 times a week, 60 minutes a day.

Primary outcomes

  1. Change in cortical excitability

    Time frame: Baseline, immediately after and 3 weeks after the intervention

    Cortical excitability will be assessed using transcranial magnetic stimulation (TMS)

Sponsors and collaborators

Lead sponsor

Hasselt University

Other

Collaborators

  • Provinciale Hogeschool Limburg

Registry information

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Jan 20, 2011
Registry last updated
Sep 5, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.